Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

A Pilot Efficacy and Implementation Study of the Strengths Intervention Project (SIP)

14 ottobre 2019 aggiornato da: Children's Hospital of Philadelphia
The purpose of this study is to test a strengths-based intervention to be delivered in a primary care setting with adolescents and a parent. Investigators want to find out if the intervention can help parents and teens communicate. Specifically Investigators want to see if they can help parents and teens identify and build teen's strengths. Half the dyads will receive the educational materials in conjunction with their teen's well-child visit, while the other half will receive usual care at the well-child visit and receive the educational materials at the end of the study. Additionally, Investigators expect that a strengths-based intervention may also impact adherence to treatment in youth with a chronic illness. As such, Investigators will include a subgroup of teenagers diagnosed with asthma in this study, to assess whether the strengths-based intervention that the Investigators developed has an impact on adherence.

Panoramica dello studio

Descrizione dettagliata

Recent research suggests that parents and adolescents report an interest in doctors facilitating increased parent-teen communication about teen strengths. However, little research focuses on how to address this need in a primary care setting. Content from subject matter experts along with data gathered from parents and teens were used to develop a novel strengths-based intervention to be tested in primary care.

The study intervention being examined is called the Strengths Intervention Project and includes a written pamphlet, a guided discussion activity, in-person/phone health coaching, and in-person or mailed health care provider endorsement and key messaging. Measures will be collected at baseline pre-intervention (T1), in clinic or over the phone at the time of the intervention (T2), approximately two weeks post-intervention (T3), and approximately 2 months post-intervention (T4). Daily diaries will also be utilized twice to gather data pre- and post- intervention. We will measure feasibility of clinic implementation of intervention, as well as influence of intervention on parent-teen communication and adolescent outcomes.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

174

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Pennsylvania
      • Philadelphia, Pennsylvania, Stati Uniti, 19104
        • The Children's Hospital of Philadelphia

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 13 anni a 15 anni (Bambino)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Adolescent Criteria:

Inclusion Criteria:

  1. Teens age 13 to 15 years at the time of their upcoming well-child visit (Arm 1) OR Teens age 13 to 15 years at the time of their last well-child visit (Arm 2)
  2. Children's Hospital of Philadelphia (CHOP) primary care patient (Arm 1 and 2)
  3. Scheduled for a well-child visit that parent and teen both plan to attend (Arm 1) OR Attended a well-child visit with parent (Arm 2)
  4. Diagnosed with Asthma > year (asthma subgroup; Arm 1 only)
  5. Prescribed a controller medication year-round (asthma subgroup; Arm 1 only)
  6. Adolescent has their own email account to complete electronic surveys (Arm 1 and 2)

Exclusion Criteria:

  1. Not fluent in written or spoken English (Arm 1 and 2)
  2. Attending a new patient well-child visit (Arm 1) OR attended a new patient well-child visit (Arm 2)
  3. Presence of developmental delay or pervasive developmental disorder that requires special education services (Arm 1 and 2)
  4. Psychiatric hospitalization of the adolescent in the past year (Arm 1 and 2)
  5. Participated in studies: CHOP IRB # 15-011732 and/or CHOP IRB # 17-013895 (Arm 1 and 2)
  6. Adolescent has sibling enrolled in (IRB 18-014922) (Arm 1 and 2)

Parent Criteria:

Inclusion Criteria:

  1. Parent or legal guardian of a teen age 13 to 15 years at their upcoming well-child visit at a CHOP primary care practice (Arm 1) OR Parent or legal guardian of a teen age 13 to 15 years at their recent well-child visit at a CHOP primary care practice (Arm 2)
  2. Parent has their own email account to complete electronic surveys (Arm 1 and 2)

Exclusion Criteria:

  1. Not fluent in written or spoken English (Arm 1 and 2)
  2. Participated in studies: CHOP IRB # 15-011732 and/or CHOP IRB # 17-013895 (Arm 1 and 2)

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Intervention Group (Arm 1- Main)
Will receive the "Build Your Teen's Strengths" educational pamphlet, health coaching sessions, and provider endorsement.
This is a clinic based psychoeducational intervention for adolescent patients and their parents to improve parent-teen communication about teen strengths. The intervention is designed, if possible, to coincide with the adolescent patients' well-child visits and consists of the following components: (1) In-person or over the phone orientation session with a trained health coach and parent, (2) Distribution of psychoeducational materials to the parent, (3) Endorsement and delivery of key messages from the health care provider, and (4) "Booster" phone call placed by the health coach.
Nessun intervento: Control Group (Arm 1- Main)
Will receive usual care at well-child visit.
Sperimentale: Intervention Group (Arm 1-asthma subgroup)
Will receive the "Build Your Teen's Strengths" educational pamphlet, health coaching sessions, and provider endorsement.
This is a clinic based psychoeducational intervention for adolescent patients and their parents to improve parent-teen communication about teen strengths. The intervention is designed, if possible, to coincide with the adolescent patients' well-child visits and consists of the following components: (1) In-person or over the phone orientation session with a trained health coach and parent, (2) Distribution of psychoeducational materials to the parent, (3) Endorsement and delivery of key messages from the health care provider, and (4) "Booster" phone call placed by the health coach.
Nessun intervento: Control Group (Arm 1-asthma subgroup)
Will receive usual care at well-child visit.
Nessun intervento: Control Group (Arm 2)
Convenience sample used for a post-hoc, exploratory analysis. Will receive usual care at well-child visit.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Beliefs about Adolescents
Lasso di tempo: Baseline (T1) and 2-months (T4)
26 items (parents only); Likert scale (1= very unlikely; 7= very, very likely)
Baseline (T1) and 2-months (T4)
Change in Parent-Adolescent Communication (PACS)
Lasso di tempo: Baseline (T1) and 2-months (T4)
20 items (parent and teens); Likert scale (1= strongly disagree; 5= strongly agree)
Baseline (T1) and 2-months (T4)
Change in Confidence in exploring and using adolescent's strengths
Lasso di tempo: Baseline (T1) and 2-months (T4)
15 items (parents and teens); Likert scale (1=strongly disagree; 5= strongly agree)
Baseline (T1) and 2-months (T4)
Feasibility of consent rates
Lasso di tempo: 9 months
Feasibility will be demonstrated by consent rates ≥60%
9 months
Feasibility of intervention implementation
Lasso di tempo: 1 month
Completion of core intervention components ≥ 70%.
1 month
Parent and adolescent acceptability of intervention materials
Lasso di tempo: 2-weeks post intervention (T3)
Adolescent and parent acceptability ratings ≥80%. Investigators will also elicit open-ended feedback.
2-weeks post intervention (T3)
Parent and adolescent acceptability of intervention materials (additional)
Lasso di tempo: 2-months post intervention (T4)
2 items (parents and teens); Yes/No/Not sure and Likert scale (1=very likely; 5 very unlikely)
2-months post intervention (T4)
Provider acceptability of intervention
Lasso di tempo: 9 months
Provider acceptability ratings ≥80%. Investigators will also elicit open-ended feedback.
9 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Psychological well-being using the Flourishing Scale
Lasso di tempo: Baseline (T1) and 2-months (T4)
Measure of psychological well-being. 8 items (parents and teens). (Likert scale 1= Strongly disagree; 2= Disagree; 3= Slightly disagree; 4= Mixed or neither agree nor disagree; 5= Slightly agree; 6= Agree; 7= Strongly agree). Score will be summed for range of 8 (Strong Disagreement with all items) to 56 (Strong Agreement with items). High scores signify that respondents view themselves in positive terms in important areas of functioning.
Baseline (T1) and 2-months (T4)
Change in Adherence to inhaled controller medication use
Lasso di tempo: Baseline (T1) and 2-months (T4)
2-items about adherence to inhaled controller medication use (parent and teen) will be assessed using the Visual analog scale (0-10).
Baseline (T1) and 2-months (T4)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Victoria A Miller, PhD, Children's Hospital of Phiadelphia

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

4 maggio 2018

Completamento primario (Effettivo)

31 maggio 2019

Completamento dello studio (Effettivo)

31 maggio 2019

Date di iscrizione allo studio

Primo inviato

21 marzo 2018

Primo inviato che soddisfa i criteri di controllo qualità

11 aprile 2018

Primo Inserito (Effettivo)

12 aprile 2018

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

15 ottobre 2019

Ultimo aggiornamento inviato che soddisfa i criteri QC

14 ottobre 2019

Ultimo verificato

1 ottobre 2019

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 18-014922

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi